Live
- They always want me to win, and now I feel lucky to have been offered a story like ‘Zebra’: Satyadev Kancharana
- ‘Democracy first, humanity first’: PM Modi in Guyana's parliament on two countries' similarities
- PKL Season 11: Telugu Titans register third straight win to top standings
- Is Pollution Contributing to Your COPD?
- NASA Unveils Underwater Robots for Exploring Jupiter's Moons
- Additional Central forces arrive in violence-hit Manipur
- AR Rahman and Saira Banu’s Divorce: Legal Insights into Common Issues in Bollywood Marriages
- 82.7 pc work completed in HPCL Rajasthan Refinery area: official
- Curfew relaxation extended in 5 Manipur districts on Friday
- Tab scam prompts Bengal govt to adopt caution over fund disbursement
IIT Delhi transfers 2 indigenous health technologies to industry
Two indigenous healthcare technologies developed by the Indian Institutes of Technology (IIT) researchers were transferred to industry, the Ministry of Electronics and Information Technology (MeitY) said on Thursday.
New Delhi: Two indigenous healthcare technologies developed by the Indian Institutes of Technology (IIT) researchers were transferred to industry, the Ministry of Electronics and Information Technology (MeitY) said on Thursday.
The technologies aim to detect prostate cancer and infectious pathogens early.
DNA Aptamer for prostate cancer detection was transferred to Swapnil Sinha, HUMMSA Biotech, Kolkata, and photonic chip-based spectrometric biosensor technology for pathogen detection was given to Nitin Zaveri, UNINO Healthcare, Mumbai.
Developed under the MeitY-funded project called Nanoelectronics Network for Research and Applications (NNetRA), the technologies were transferred on July 31, at an event hosted by the Indian Institute of Technology Delhi.
"We envision a future where technology transfer drives innovation, collaboration, and sustainable development. Measures should be taken to ensure successful adoption, implementation, and commercialisation of technology," said S. Krishnan, Secretary, MeitY.
The aptamer, developed by Prashant Mishra and team from IIT Delhi is capable of binding to the specific oncogenes and could be useful as theranostics for prostate cancer.
On the other hand, the spectrometric biosensor was developed by Joby Joseph and the team from IIT Delhi. It will enable quick and accurate detection of pathogens, thereby aiding in preventing infectious diseases.
